000 01424 a2200397 4500
005 20250515123924.0
264 0 _c20080731
008 200807s 0 0 eng d
022 _a1064-590X
040 _aNLM
_beng
_cNLM
100 1 _aPatsner, Bruce
245 0 0 _aPharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
_h[electronic resource]
260 _bFood and drug law journal
_c2008
300 _a459-91 p.
_bdigital
500 _aPublication Type: Historical Article; Journal Article
650 0 4 _aAdvertising
650 0 4 _aBiological Products
_xtherapeutic use
650 0 4 _aConsumer Product Safety
_xlegislation & jurisprudence
650 0 4 _aDrug Approval
650 0 4 _aDrug Compounding
_xhistory
650 0 4 _aDrug Industry
650 0 4 _aDrug Prescriptions
650 0 4 _aHistory, 20th Century
650 0 4 _aHormone Replacement Therapy
650 0 4 _aHumans
650 0 4 _aInternet
650 0 4 _aLegislation, Drug
650 0 4 _aMenopause
_xdrug effects
650 0 4 _aOrganizations
650 0 4 _aPharmaceutical Services
_xlegislation & jurisprudence
650 0 4 _aTerminology as Topic
650 0 4 _aTherapeutic Equivalency
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
773 0 _tFood and drug law journal
_gvol. 63
_gno. 2
_gp. 459-91
999 _c18046178
_d18046178